As of close of business last night, Wave Life Sciences Ltd.’s stock clocked out at $3.81, up 2.70% from its previous closing price of $3.71. In other words, the price has increased by $+0.1000 from its previous closing price. On the day, 1000676 shares were traded. WVE stock price reached its highest trading level at $4.0899 during the session, while it also had its lowest trading level at $3.2000.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
To gain a deeper understanding of WVE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 1.70.
Upgrades & Downgrades
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 16 when BOLNO PAUL sold 29,400 shares for $4.04 per share. The transaction valued at 118,776 led to the insider holds 407,425 shares of the business.
Francis Chris sold 10,258 shares of WVE for $41,340 on Feb 16. The insider now owns 79,714 shares after completing the transaction at $4.03 per share. On Feb 16, another insider, Vargeese Chandra, who serves as the insider of the company, sold 10,249 shares for $4.03 each. As a result, the insider received 41,303 and left with 106,624 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 361.03M and an Enterprise Value of 310.14M. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.11. Its current Enterprise Value per Revenue stands at 20.92 whereas that against EBITDA is -2.14.
Stock Price History:
Over the past 52 weeks, WVE has reached a high of $7.12, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 4.0748, while the 200-Day Moving Average is calculated to be 4.2546.
It appears that WVE traded 346.81K shares on average per day over the past three months and 391.47k shares per day over the past ten days. A total of 102.06M shares are outstanding, with a floating share count of 72.78M. Insiders hold about 25.16% of the company’s shares, while institutions hold 78.70% stake in the company. Shares short for WVE as of Apr 27, 2023 were 1.95M with a Short Ratio of 1.95M, compared to 2.02M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.99% and a Short% of Float of 3.05%.
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.35 for the current quarter, with a high estimate of -$0.26 and a low estimate of -$0.42, while EPS last year was -$0.62. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.27 and low estimates of -$0.43.
Analysts are recommending an EPS of between -$1 and -$1.57 for the fiscal current year, implying an average EPS of -$1.35. EPS for the following year is -$1.33, with 6 analysts recommending between -$0.71 and -$1.73.
In the current quarter, 7 analysts expect revenue to total $6.25M. It ranges from a high estimate of $15M to a low estimate of $250k. As of the current estimate, Wave Life Sciences Ltd.’s year-ago sales were $375k, an estimated increase of 1,566.70% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $6.97M, an increase of 2,345.60% over than the figure of $1,566.70% in the same quarter last year. There is a high estimate of $15M for the next quarter, whereas the lowest estimate is $300k.
A total of 7 analysts have provided revenue estimates for WVE’s current fiscal year. The highest revenue estimate was $60.6M, while the lowest revenue estimate was $13.73M, resulting in an average revenue estimate of $33.51M. In the same quarter a year ago, actual revenue was $3.65M, up 818.30% from the average estimate.